Previous issue | Volume 84 | ESPE2015 | Next issue

54th Annual ESPE

Barcelona, Spain
01 Oct 2015 - 03 Oct 2015

Card image cap
Barcelona, Spain; 1-3 October 2015 Further information

Poster Category 3

Turner

Growth Curves for Turkish Girls with Turner Syndrome: Results of the Turkish Turner Syndrome Study Group
aIstanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey; bFaculty of Medicine, Marmara University, Istanbul, Turkey; cGulhane Military Medicine Academy, Ankara, Turkey; dFaculty of Medicine, Ege University, Izmir, Turkey; eFaculty of Medicine, Izmir Katip Çelebi University, Izmir, Turkey; fKonya Training and Research Hospital, Konya, Turkey; gFaculty of Medicine, Mayis University, Samsun, Turkey; hFaculty of Medicine, Erciyes University, Kayseri, Turkey; iKanuni Sultan Süleyman Training and Research Hospital, Istanbul, Turkey; jFaculty of Medicine, Inonu University, Malatya, Turkey; kFaculty of Medicine, Necmettin Erbakan University, Konya, Turkey; lYildirim Beyazit University, Ankara, Turkey; mFaculty of Medicine, Gazi University, Ankara, Turkey, nDr Behçet Uz Children Hospital, Izmir, Turkey; oFaculty of Medicine, Osmangazi University, Eskisehir, Turkey; pFAVOR for Pediatric Endocrinology, Ankara, Turkey
hrp0084p3-1233
Cardiovascular Assessment in Turner Syndrome: Current Practice in the United Kingdom
aDevelopmental Endocrinology Research Group, Royal Hospital for Sick Children, Glasgow, UK; bTurner Syndrome Society United Kingom, Glasgow, UK
hrp0084p3-1234
Turner Syndrome in Iceland 1968-2012: Congenital Anomalies and Clinical Outcomes
aChildren’s Medical Center, Landspitali University Hospital, Reykjavik, Iceland; bDepartment of Genetics and Molecular Medicine, Landspitali University Hospital, Reykjavik, Iceland; cDepartment of Endocrinology, Landspitali University Hospital, Reykjavik, Iceland; dFaculty of Medicine, University of Iceland, Reykjavik, Iceland
hrp0084p3-1235
A Comparison of Efficacies between rhGH and rhGH Combined with Stanozolol Therapies in Growth of the Girls with Turner Syndrome
Pediatric Department, First Affiliated Hospital, Sun Yat-Sen University, GuangZhou, China
hrp0084p3-1236
Growth Characteristics of Patient with Turner Syndrome Different Age and Karyotypes by the Ukrainian National Register
aUkrainian Scientific and Practical Center of Endocrine Surgery, Transplantation of Endocrine Organs and Tissues of the Ministry of Health of Ukraine, Kiev, Ukraine; bNation Children’s Specialized Hospital ‘Okhmatdet’, Kiev, Ukraine
hrp0084p3-1238
Nationwide Study of Turner Syndrome in Ukraine
aUkrainian Center of Endocrine Surgery, Endocrine Organs and Tissue Transplatation, MOH of Ukraine, Kiev, Ukraine; bNational Children’s Specialized Hospital ‘OHMATDIT’, Kiev, Ukraine
hrp0084p3-1239
Renal Problems in Early Adult Patients with Turner Syndrome
Busan Paik Hospital, Busan, Republic of Korea
hrp0084p3-1241
To Predict Ovarian Function is a Single Determination of AMH Useful in Patients with Turner Syndrome?
aPediatric Clinic, Department of Life and Reproduction Sciences, University of Verona, Verona, Italy; bClinical Chemistry Section, Department of Life and Reproductive Sciences, University of Verona, Verona, Italy
hrp0084p3-1242
Anthropometric Findings from Birth to Adulthood in Turkish Girls with Turner Syndrome and Association with Karyotpye Distribution
aGulhane Military Medicine Academy, Ankara, Turkey; bMarmara University Faculty of Medicine, Istanbul, Turkey; cIstanbul University Istanbul Faculty of Medicine, Istanbul, Turkey; dEge University Faculty of Medicine, Izmir, Turkey; eIzmir Katip Çelebi University Faculty of Medicine, Izmir, Turkey; fKonya Training and Research Hospital, Konya, Turkey; g19 Mayis University Faculty of Medicine, Samsun, Turkey; hKanuni Sultan Süleyman University Faculty of Medicine, Istanbul, Turkey; iInonu University Faculty of Medicine, Malatya, Turkey; jNecmettin Erbakan University Faculty of Medicine, Konya, Turkey; kYildirim Beyazit University, Ankara, Turkey; lGazi University Faculty of Medicine, Ankara, Turkey; mDr. Behçet Uz Children Hospital, Izmir, Turkey; nPamukkale University Faculty of Medicine, Denizli, Turkey; oAtatürk University Faculty of Medicine, Erzurum, Turkey; pIstanbul University Cerrahpasa Faculty of Medicine, Istanbul, Turkey; qFAVOR for Pediatric Endocrinology, Ankara, Turkey
hrp0084p3-1243
GH Therapy in Turner Syndrome
aUniversity of Medicine and Pharmacy ‘Gr. T. Popa’, Iasi, Romania; bRomanian Academy of Medical Sciences, Iasi, Romania
hrp0084p3-1244
A Rare Variant of Turner Syndrome: First Clinical Report from Kuwait
aMinistry of Health, Kuwait, Kuwait; bDepartment of Pediatrics, Faculty of Medicine, Kuwait University, Kuwait, Kuwait
hrp0084p3-1245
Turner Syndrome with Breast Development: Case Report
aCheil General Hospital, Seoul, Republic of Korea; bSamsung Medical Center, Seoul, Republic of Korea; cMyongji Hospital, Seoul, Republic of Korea
hrp0084p3-1246